Compare Cassava Sciences Inc (FLNA) vs TKO Group Holdings Inc (TKO) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

TKO trades at $182.895, down 0.9% on the day, with a bearish technical signal despite strong analyst support. The company shows solid revenue growth from $4.74B in 2025 to $5.1B projected for 2026, though net margins remain modest at 4.47%. Recent developments include successful international events and an $800 million share repurchase, while technical indicators show support at $180 and resistance at $188.

The stock presents a mixed outlook with strong Wall Street bullishness (89% buy ratings) and a $228.40 price target offering 25% upside potential. However, elevated P/E ratio of 69.03 and recent earnings misses create valuation concerns. Key risks include execution challenges in monetizing live events and competitive pressures in sports entertainment.